Finally, inhibitors of HO-1 have been shown to decrease proliferation, migration, and invasion of follicular thyroid carcinoma (FTC) and UTC cell lines, and to reduce FTC tumor growth in a xenograft model (89). Here, HMOX1 is linked to thyroid cancer, nonmedullary, 2.